Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Joseph Edelman’s Perceptive Advisors Buys More AcelRx Pharmaceuticals

Joseph Edelman‘s fund, Perceptive Advisors, in a new filing reported increasing its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) again, after disclosing a buy of around 360,700 shares a couple of days ago. This time, Perceptive acquired 155,000 shares, bringing the position to a total of some 6.37 million shares. The average purchase price amounts to around $6.87 per share.

AcelRx Pharmaceuticals Inc

Disclosure: none

Recommended Reading:

Heartland Advisors Discloses Changes in its Albany International and Gulf Island Holdings

Bill Ackman Cuts Stake in LSE-listed Platform Specialty Products

Chuck Royce Discloses Moves in Vera Bradley, Graham Corp & Others

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!